title: Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine.
authors.affiliation: Baskent University School of Medicine, Department of Medical Oncology, Adana, Turkey.
authors.forename: Umut
authors.initials: U
authors.lastname: Disel
authors.forename: Ozlem
authors.initials: O
authors.lastname: Gürkut
authors.forename: Hüseyin
authors.initials: H
authors.lastname: Abali
authors.forename: Hakan
authors.initials: H
authors.lastname: Kaleağasi
authors.forename: Hüseyin
authors.initials: H
authors.lastname: Mertsoylu
authors.forename: Ozgür
authors.initials: O
authors.lastname: Ozyilkan
authors.forename: Muhammad Wasif
authors.initials: MW
authors.lastname: Saif
mesh_terms: D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D001284:Atrophy; D000069287:Capecitabine; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D054067:Dihydropyrimidine Dehydrogenase Deficiency; D004890:Erythema / Q000139:chemically induced* / Q000473:pathology; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005528:Foot / Q000473:pathology*; D007839:Functional Laterality; D006225:Hand / Q000473:pathology*; D006801:Humans; D008297:Male; D013274:Stomach Neoplasms / Q000150:complications / Q000188:drug therapy
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil